| Name | Title | Contact Details |
|---|
The Federal Reserve Board, commonly known as the Fed, is the central authority of the Federal Reserve System, which serves as the central banking system of the United States. Established in 1913, the Fed aims to create a stable monetary system and address banking panics. Headquartered in Washington, D.C., it oversees 12 regional Federal Reserve Banks, balancing regional insights with national policy. The Fed has five main functions: conducting monetary policy to promote maximum employment and stable prices, ensuring financial system stability, supervising and regulating financial institutions, fostering efficient payment and settlement systems, and promoting consumer protection and community development. It also provides essential services such as payment processing and economic data publications, including the Beige Book and the FRED database. The Fed plays a crucial role in supporting the U.S. economy and serves various stakeholders, including depository institutions, the U.S. government, and foreign official institutions.
Nos hemos asociado varias agencias de seguros colombianas con tradición en el mercado y un fondo de inversión americano para formar una red de distribución de seguros en Colombia, con planes de expansión a Centro y Suramérica. Cada agencia mantendrá su independencia bajo la Holding "Grupo ilao", que proporcionará estrategia, software especializado, desarrollo de nuevos productos, reaseguros y conexiones internacionales.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
PetVet Dx is a therapeutic management company focusing on delivering affordable, accurate, and rapid diagnostics with cutting-edge molecular technology and pharmaceuticals for veterinarians, farmers, and pet owners.